<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gerberich BG</submitter><funding>Oak Ridge Institute for Science and Education</funding><funding>NEI NIH HHS</funding><funding>RRD VA</funding><funding>National Institutes of Health</funding><funding>US Department of Veterans Affairs</funding><pagination>120735</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8044034</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>271</volume><pubmed_abstract>The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral region immediately adjacent to the optic nerve head. Previous scleral stiffening studies to treat glaucoma or myopia have used either pan-scleral stiffening (not regionally selective) or regionally selective stiffening with limited access to the posterior globe. We present a method for selectively stiffening the peripapillary sclera using a transpupillary annular light beam to activate methylene blue administered by retrobulbar injection. Unlike prior approaches to photocrosslinking in the eye, </pubmed_abstract><journal>Biomaterials</journal><pubmed_title>Transpupillary collagen photocrosslinking for targeted modulation of ocular biomechanics.</pubmed_title><pmcid>PMC8044034</pmcid><funding_grant_id>IK2 RX002342</funding_grant_id><funding_grant_id>IK6 RX003134</funding_grant_id><funding_grant_id>R01 EY025286</funding_grant_id><pubmed_authors>Hejri A</pubmed_authors><pubmed_authors>MacLeod NA</pubmed_authors><pubmed_authors>Read AT</pubmed_authors><pubmed_authors>Toothman MG</pubmed_authors><pubmed_authors>Ethier CR</pubmed_authors><pubmed_authors>Gerberich BG</pubmed_authors><pubmed_authors>Sridhar S</pubmed_authors><pubmed_authors>Gersch HG</pubmed_authors><pubmed_authors>Gupta S</pubmed_authors><pubmed_authors>Goyal V</pubmed_authors><pubmed_authors>Pardue MT</pubmed_authors><pubmed_authors>Toporek AM</pubmed_authors><pubmed_authors>Hannon BG</pubmed_authors><pubmed_authors>Schwaner SA</pubmed_authors><pubmed_authors>Gershon GS</pubmed_authors><pubmed_authors>Sanchez-Rodriguez G</pubmed_authors><pubmed_authors>Nichols LM</pubmed_authors><pubmed_authors>Feola AJ</pubmed_authors><pubmed_authors>Ritch MD</pubmed_authors><pubmed_authors>Prausnitz MR</pubmed_authors><pubmed_authors>Winger EJ</pubmed_authors><pubmed_authors>Grossniklaus HE</pubmed_authors><pubmed_authors>Schrader Echeverri E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transpupillary collagen photocrosslinking for targeted modulation of ocular biomechanics.</name><description>The central vision-threatening event in glaucoma is dysfunction and loss of retinal ganglion cells (RGCs), thought to be promoted by local tissue deformations. Here, we sought to reduce tissue deformation near the optic nerve head by selectively stiffening the peripapillary sclera, i.e. the scleral region immediately adjacent to the optic nerve head. Previous scleral stiffening studies to treat glaucoma or myopia have used either pan-scleral stiffening (not regionally selective) or regionally selective stiffening with limited access to the posterior globe. We present a method for selectively stiffening the peripapillary sclera using a transpupillary annular light beam to activate methylene blue administered by retrobulbar injection. Unlike prior approaches to photocrosslinking in the eye, </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Apr</publication><modification>2025-04-29T11:34:48.802Z</modification><creation>2025-04-06T19:54:54.003Z</creation></dates><accession>S-EPMC8044034</accession><cross_references><pubmed>33721571</pubmed><doi>10.1016/j.biomaterials.2021.120735</doi></cross_references></HashMap>